Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Page 1
Long-term outcomes and immune profiling in children with multisystem inflammatory syndrome (MIS-C).
Jaxybayeva I, Boranbayeva R, Bulegenova M, Urazalieva N, Gerein V, Manzhuova L. Jaxybayeva I, et al. Among authors: gerein v. Acta Biomed. 2023 Dec 5;94(6):e2023233. doi: 10.23750/abm.v94i6.14788. Acta Biomed. 2023. PMID: 38054683 Free PMC article.
BACKGROUND AND AIM: Existing follow-up data after MIS-C is limited. PURPOSE OF THE STUDY: to investigate the long-term consequences in children who have undergone MIS-C. METHODS: The retrospective study included 93 children. ...CONCLUSIONS: After the history of MIS-C, chil …
BACKGROUND AND AIM: Existing follow-up data after MIS-C is limited. PURPOSE OF THE STUDY: to investigate the long-term consequences i …
CD15 - a new marker of pathological villous immaturity of the term placenta.
Seidmann L, Suhan T, Kamyshanskiy Y, Nevmerzhitskaya A, Gerein V, Kirkpatrick CJ. Seidmann L, et al. Among authors: gerein v. Placenta. 2014 Nov;35(11):925-31. doi: 10.1016/j.placenta.2014.07.018. Epub 2014 Aug 12. Placenta. 2014. PMID: 25149387
The aim of the study was to determine the relevant diagnostic markers associated with pathological placental immaturity. METHODS: 111 tissue samples from normal and pathological term placentas with persisting villous immaturity comprised the comparative immunohistochemical …
The aim of the study was to determine the relevant diagnostic markers associated with pathological placental immaturity. METHODS: 111 tissue …
Transient CD15-positive endothelial phenotype in the human placenta correlates with physiological and pathological fetoplacental immaturity.
Seidmann L, Suhan T, Unger R, Gerein V, Kirkpatrick CJ. Seidmann L, et al. Among authors: gerein v. Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:172-9. doi: 10.1016/j.ejogrb.2014.06.022. Epub 2014 Jul 1. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25043745
STUDY DESIGN: Forty tissue samples from normal placentas of different gestational age and 68 pathological term placentas with defective villous maturation (GDM, idiopathic IUFD, preeclamsia, HELLP syndrome) comprised the comparative immunohistochemical study (CD15, CD45 an …
STUDY DESIGN: Forty tissue samples from normal placentas of different gestational age and 68 pathological term placentas with defecti …
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M; German-Austrian-Swiss ALL-BFM Study Group. Möricke A, et al. Blood. 2008 May 1;111(9):4477-89. doi: 10.1182/blood-2007-09-112920. Epub 2008 Feb 19. Blood. 2008. PMID: 18285545 Free article. Clinical Trial.
The trial ALL-BFM 95 for treatment of childhood acute lymphoblastic leukemia was designed to reduce acute and long-term toxicity in selected patient groups with favorable prognosis and to improve outcome in poor-risk groups by treatment intensification. ...
The trial ALL-BFM 95 for treatment of childhood acute lymphoblastic leukemia was designed to reduce acute and long-term toxicity in s …
Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.
Gerein V, Rastorguev E, Gerein J, Jecker P, Pfister H. Gerein V, et al. Ann Otol Rhinol Laryngol. 2005 Jun;114(6):463-71. doi: 10.1177/000348940511400608. Ann Otol Rhinol Laryngol. 2005. PMID: 16042104 Clinical Trial.
METHODS: A multicenter prospective series (42 patients from 22 hospitals) yielded 20 years of follow-up of patients with RRP and HPV typing who were treated with IFN-alpha in doses of 3 MU/m2 3 times per week. RESULTS: During long-term follow-up (mean +/- SD, 172 +/- 36.8 …
METHODS: A multicenter prospective series (42 patients from 22 hospitals) yielded 20 years of follow-up of patients with RRP and HPV typing …
Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience.
Gerein V, Rastorguev E, Gerein J, Draf W, Schirren J. Gerein V, et al. Otolaryngol Head Neck Surg. 2005 Mar;132(3):392-4. doi: 10.1016/j.otohns.2004.09.035. Otolaryngol Head Neck Surg. 2005. PMID: 15746849
Five patients (4/5 smokers) presented malignant transformation in lungs or nasopharynx (mean RRP duration was 27.2 +/- 8 years from RRP onset and 14.6 +/- 6.3 years from pulmonary spread until malignant transformation) with persistent RRP in larynx. The results of long-term …
Five patients (4/5 smokers) presented malignant transformation in lungs or nasopharynx (mean RRP duration was 27.2 +/- 8 years from RRP onse …
2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V, Rastorguev E, Gerein J, Lodemann E, Pfister H, Draf W, Desloovere C. Gerein V, et al. J Laryngol Otol. 2004 Oct;118(10):750-6. doi: 10.1258/0022215042450733. J Laryngol Otol. 2004. PMID: 15550179
Human papilloma virus (HPV) type, recurrent respiratory papillomatosis severity and 2',5'-oligoadenylate synthetase activity were determined by standard methods and analysed for correlation with the results of long-term clinical outcome. RESULTS AND CONCLUSION: Patients wi …
Human papilloma virus (HPV) type, recurrent respiratory papillomatosis severity and 2',5'-oligoadenylate synthetase activity were determined …
Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P, Feller AC, Reiter A, Beck J, Bertram U, Eschenbach C, Gerein V, Lakomek M, Stollmann B, Tausch W, et al. Bucsky P, et al. Among authors: gerein v. Klin Padiatr. 1990 Jul-Aug;202(4):258-61. doi: 10.1055/s-2007-1025530. Klin Padiatr. 1990. PMID: 2203939 Clinical Trial.
Cells of low grade malignant NHL (LG-NHL) of B cell type represent either follicular or postfollicular, cells of LG-NHL of T cell type postthymic maturation stages in the lymphoid differentiation pathway. LG-NHL often fail to undergo long-term complete remission or cure in …
Cells of low grade malignant NHL (LG-NHL) of B cell type represent either follicular or postfollicular, cells of LG-NHL of T cell type postt …
13 results